000 01504 a2200457 4500
005 20250518055922.0
264 0 _c20200803
008 202008s 0 0 eng d
022 _a1424-3997
024 7 _a10.4414/smw.2019.20121
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnkli, Barbara
245 0 0 _aThe target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort.
_h[electronic resource]
260 _bSwiss medical weekly
_cAug 2019
300 _aw20121 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAllopurinol
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aGout
_xblood
650 0 4 _aGout Suppressants
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLongitudinal Studies
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultimorbidity
650 0 4 _aPatient Acceptance of Health Care
_xstatistics & numerical data
650 0 4 _aSwitzerland
650 0 4 _aUric Acid
_xblood
650 0 4 _aYoung Adult
700 1 _aBerger, Christoph T
700 1 _aHaeni, Nicolas
700 1 _aKyburz, Diego
700 1 _aHügle, Thomas
700 1 _aSo, Alexander K-L
700 1 _aDaikeler, Thomas
773 0 _tSwiss medical weekly
_gvol. 149
_gp. w20121
856 4 0 _uhttps://doi.org/10.4414/smw.2019.20121
_zAvailable from publisher's website
999 _c30067979
_d30067979